Currently, this website is not being updated or actively managed. Messages and webform submissions sent to the PRIMED Coordinating Center are also not being monitored or responded to at this time. This message will be removed when normal operations have resumed.
GenomeWeb spoke with PRIMED investigators for this article highlighting how PRIMED is improving genetic risk estimates in diverse global populations. The piece features contributions from Consortium members Iftikhar Kullo, James Meigs, Jaewon Choi, and Soo-Heon Kwak in advancing PRS for type 2 diabetes and cardiovascular disease.
Source
GenomeWeb
Date
08/22/2024